Jupiter Neurosciences Inc., a clinical-stage pharmaceutical company developing JOTROL, a patented resveratrol-based platform, ...

Jupiter Neurosciences (JUNS) announced it has entered into an agreement with Catalent Pharma Solutions for the production of JOTROL softgel ...

JOTROL is designed to overcome the historical challenges of resveratrol by significantly enhancing bioavailability while minimizing gastrointestinal side effects. The upcoming Phase 2a trial will ...

The global enteric softgel capsules market is poised for significant growth, according to recent research by Future Market ...

The global softgel encapsulation machine market is poised for substantial growth over the next decade, with a projected valuation of USD 178.8 million by 2035. This represents a c ...

January 27, 2025. More for You ...

Patheon Inc is to launch the company’s capabilities at FCE Pharma in Sao Paulo, Brazil, 12-14 May 2014. Patheon ...

Patheon will showcase its offerings, including non-sterile, sterile and softgel dose forms at CPhI/ICSE in Messe Frankfurt, Germany, 22-24 ...

The company posted strong sales growth in 2024, though share-based compensation expenses weighed on its bottom line.